Anixa Biosciences, Inc.
(NASDAQ : ANIX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 7.97%146.630.0%$968.17m
AMGNAmgen, Inc. 0.69%254.801.5%$857.87m
GILDGilead Sciences, Inc. 0.26%64.641.0%$546.26m
VRTXVertex Pharmaceuticals, Inc. 1.34%273.251.9%$494.23m
REGNRegeneron Pharmaceuticals, Inc. 1.33%692.512.6%$440.30m
ILMNIllumina, Inc. 5.11%256.033.3%$329.50m
NVAXNovavax, Inc. 17.55%55.3375.7%$303.79m
BIIBBiogen, Inc. 0.51%205.271.8%$233.90m
BNTXBioNTech SE 4.87%165.850.0%$221.26m
SNSSSunesis Pharmaceuticals, Inc. 1.43%2.130.7%$148.89m
EXASEXACT Sciences Corp. 7.22%53.4617.7%$137.45m
TXG10X Genomics, Inc. 10.86%52.490.0%$105.43m
TECHBio-Techne Corp. 4.68%382.404.5%$105.00m
BMRNBioMarin Pharmaceutical, Inc. 2.21%80.604.2%$96.63m
CRSPCRISPR Therapeutics AG 5.36%58.190.6%$84.70m

Company Profile

Anixa Biosciences, Inc. is a biotechnology company, which engages in developing therapies and vaccines that are focused on critical unmet needs in oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, Cancer Diagnostics, and Patent Licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.